Breast MRI Can Be Safely Omitted in Selected Patients With Early-Stage HR-Negative Breast Cancer: Study

Day 1 conference highlights include news from Moderna, BridgeBio

DRRA3 days ago 0

FDA again rejects tabelecleucel for EBV-driven post-transplant lymphoproliferative disease

DRRA3 days ago 0

New data, nuances in managing resistant gram-negative infections

DRRA3 days ago 0

New Year’s resolutions 2026: Lessons from colleagues

DRRA3 days ago 0